n-vinyl-2-pyrrolidinone has been researched along with Candidiasis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galigama, RD; Garg, P; Mallela, LS; Roy, G; Roy, S; Thorat, VS; Venuganti, VVK | 1 |
Georgiade, NG; Harris, WA | 1 |
Morere, P; Nouvet, G; Stain, JP | 1 |
3 other study(ies) available for n-vinyl-2-pyrrolidinone and Candidiasis
Article | Year |
---|---|
Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
Topics: Administration, Ophthalmic; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Compressive Strength; Disease Models, Animal; Dosage Forms; Drug Compounding; Drug Delivery Systems; Eye Infections, Fungal; Humans; Keratitis; Male; Miniaturization; Needles; Permeability; Phosphatidylcholines; Polyvinyl Alcohol; Povidone; Rabbits | 2019 |
Open and closed treatment of burns with povidone-iodine.
Topics: Administration, Topical; Adolescent; Adult; Aged; Burns; Candidiasis; Child; Child, Preschool; Escherichia coli Infections; Female; Humans; Infant; Infection Control; Klebsiella Infections; Male; Middle Aged; Ointments; Povidone; Povidone-Iodine; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections | 1973 |
[Prevention of intestinal disorders following oral administration of antibiotics, using polyvinylpolypyrrolidone].
Topics: Administration, Oral; Anti-Bacterial Agents; Candidiasis; Diarrhea; Gastrointestinal Diseases; Humans; Intestines; Povidone | 1971 |